These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 4272617)
21. [Structure, metabolism and pathophysiological importance of fibrinogen]. Lepsanovic LJ Med Pregl; 1976; 29(5-6):287-94. PubMed ID: 940540 [No Abstract] [Full Text] [Related]
22. Nature and biological activities of degradation products of fibrinogen and fibrin. Kwaan HC; Barlow GH Annu Rev Med; 1973; 24():335-44. PubMed ID: 4575863 [No Abstract] [Full Text] [Related]
23. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation]. Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289 [TBL] [Abstract][Full Text] [Related]
24. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin. Doolittle RF; Pandi L Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759 [TBL] [Abstract][Full Text] [Related]
25. A microtiter plate assay for factor XIII A-chain-fibrin interactions. Achyuthan KE; Santiago MA; Greenberg CS Anal Biochem; 1994 May; 219(1):43-8. PubMed ID: 8059954 [TBL] [Abstract][Full Text] [Related]
26. Factor XIII consumption as an indicator of thrombin generation. Triantaphyllopoulos DC J Lab Clin Med; 1974 Jul; 84(1):74-80. PubMed ID: 4833844 [No Abstract] [Full Text] [Related]
28. [Enzymatic solubility of fibrin in thrombin and in fibrinous inflammations]. Hey D; Beneke G; Sandritter W Klin Wochenschr; 1966 Jul; 44(13):770-4. PubMed ID: 4230649 [No Abstract] [Full Text] [Related]
29. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond. Bini A; Itoh Y; Kudryk BJ; Nagase H Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941 [TBL] [Abstract][Full Text] [Related]
30. Degradation of fibrinogen by proteolytic enzymes. I. Characterization and isolation of products and their relation to fibrinolytic states. Sanchez-Avalos J; Miller SP Thromb Diath Haemorrh; 1968 Jul; 19(3):499-515. PubMed ID: 4974324 [No Abstract] [Full Text] [Related]
31. Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots. Sangrar W; Koschinsky ML Biochem Cell Biol; 2000; 78(4):519-25. PubMed ID: 11012092 [TBL] [Abstract][Full Text] [Related]
32. The conversion of fibrinogen to fibrin: A brief history of some key events. Doolittle RF Matrix Biol; 2017 Jul; 60-61():5-7. PubMed ID: 27519977 [TBL] [Abstract][Full Text] [Related]
33. Coagulation studies in patients treated with defibrase. Egberg N Acta Med Scand; 1973 Oct; 194(4):291-302. PubMed ID: 4749167 [No Abstract] [Full Text] [Related]
34. Evidence for localization of polymerization sites in fibrinogen. Kudryk BJ; Collen D; Woods KR; Blombäck B J Biol Chem; 1974 May; 249(10):3322-5. PubMed ID: 4275342 [No Abstract] [Full Text] [Related]